POST Online Media Lite Edition



 

Medical device suppliers’ merger raises CMA concerns

Christian Fernsby |
The Competition and Markets Authority (CMA) is concerned that, should the proposed £4.2 billion purchase by Stryker Corporation of Wright Medical Group N.V. go ahead, it would have a negative impact on vulnerable patients in the UK who need ankle replacements.

Article continues below



Topics: CMA   

Stryker and Wright both manufacture a range of orthopaedic products for patients requiring assistance with their feet, ankles and hands. The total ankle replacement prosthetics produced by Stryker and Wright are predominantly used in elderly orthopaedic patients suffering from arthritis.

Following its initial Phase 1 investigation, the CMA found that the proposed merger would result in the merged entity having a share of over 90% in the total ankle replacement prostheses market in the UK.

Should the deal go ahead as planned, the CMA is concerned that Stryker would not face enough competition from other suppliers, leading to higher prices or less choice for hospitals and their patients.


What to read next

Sainsbury’s-Asda merger could push up prices and reduce quality, says regulator
SSE-Npower merger provisionally cleared after in-depth review in UK
CMA to consider Mastercard/VocaLink remedies